MentionFox
Home › funding signals › Dropprint Genomics
Accelerator · announced

Dropprint Genomics (YC W20) — The better way to run single cell genomics

Who we are? We write software that understands the activity of individual cells as opposed to all cells.

Dropprint Genomics is a Y Combinator company in the Winter 2020 batch. Its directory entry describes it as: The better way to run single cell genomics. The founders listed are Rachel Gate (Founder), Meena Subramaniam (Founder), Jimmie Ye (Founder) (Y Combinator directory entry, March 10, 2020).

6 more companies from YC Winter 2020 ↓

Run the free check on Dropprint Genomics →

Sell to companies like Dropprint Genomics? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Dropprint Genomics

New accelerator entry · 2020-03-10 · the record

Winter 2020
batch
2
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchWinter 2020
Announced2020-03-10
StageEarly
StatusAcquired
Team size2
IndustryHealthcare
Sub-industryHealthcare -> Drug Discovery and Delivery
SectorsGenomics
RegionsUnited States of America, America / Canada
BasedSan Francisco, CA, USA
HiringNo
Sitehttp://dropprintgen.com/

Pitching, partnering or investing alongside them? See who really runs and owns Dropprint Genomics.

Free to see. No signup.

Keep reading

More on Dropprint Genomics and the records around it.

What do you want to do with Dropprint Genomics?

Get the full cited report on Dropprint Genomics

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Dropprint Genomics: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

Who we are? We write software that understands the activity of individual cells as opposed to all cells. This approach is novel because we are no longer looking at average signals and can be precise. It is like a police person trying to identify the speeding car, they won’t find it if they look at all the cars at once, rather they need to look at the speed of each individual car. This is the beauty of single cell genomics, we can now identify that speeding car. Why now? The biggest barrier for entry into the single cell genomics market are cost and data analysis. To that end, we have reduced the cost by 10-fold and built the computational infrastructure for scalability. Although single cell sequencing has only been around for about five years, we come from one of the top single cell genomics labs and were the first to process and analyze millions of immune cells. Thanks to our software solutions, we have been able to bring big data solutions to the immune system. Where are we and where are we going? We have generated a database of over 1 million immune cells spanning healthy, cancerous, and autoimmune immune cells and are growing through paid partnerships. Harnessing out database and ML software, we can take a data-centric approach for better target discovery. Fortunately, as our database continues to grow, our models will continue to learn for more precise, unbiased, and automated single cell genomics. Thank you!

Want the whole picture on Dropprint Genomics?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Dropprint Genomics: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Dropprint Genomics covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Dropprint Genomics: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for Dropprint Genomics. With no account yet, you sign up free and land on the result.

On these startup lists

Biotech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

Dropprint Genomics: Accepted into Y Combinator Winter 2020
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-dropprint-genomics
Last updated 2026-10-20
Primary record: Y Combinator directory entry
Dropprint Genomics (YC W20) — The better way to run single cell genomics. MentionFox, 2026-10-20. https://mentionfox.com/funding/yc-dropprint-genomics